7-21619936-A-ATTAAT

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_001277115.2(DNAH11):​c.4378-17_4378-16insATTTA variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.42 in 1,559,650 control chromosomes in the GnomAD database, including 142,372 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.45 ( 15627 hom., cov: 0)
Exomes 𝑓: 0.42 ( 126745 hom. )

Consequence

DNAH11
NM_001277115.2 intron

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.774

Publications

6 publications found
Variant links:
Genes affected
DNAH11 (HGNC:2942): (dynein axonemal heavy chain 11) This gene encodes a ciliary outer dynein arm protein and is a member of the dynein heavy chain family. It is a microtubule-dependent motor ATPase and has been reported to be involved in the movement of respiratory cilia. Mutations in this gene have been implicated in causing Kartagener Syndrome (a combination of situs inversus totalis and Primary Ciliary Dyskinesia (PCD), also called Immotile Cilia Syndrome 1 (ICS1)) and male sterility. [provided by RefSeq, Mar 2013]
DNAH11 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 7
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), ClinGen
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 7-21619936-A-ATTAAT is Benign according to our data. Variant chr7-21619936-A-ATTAAT is described in ClinVar as [Likely_benign]. Clinvar id is 93688.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.74 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAH11NM_001277115.2 linkc.4378-17_4378-16insATTTA intron_variant Intron 24 of 81 ENST00000409508.8 NP_001264044.1 Q96DT5Q96NT7H9NAJ8H9NAJ7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAH11ENST00000409508.8 linkc.4378-20_4378-19insTTAAT intron_variant Intron 24 of 81 5 NM_001277115.2 ENSP00000475939.1 Q96DT5
DNAH11ENST00000465593.1 linkn.404-20_404-19insTTAAT intron_variant Intron 2 of 3 2

Frequencies

GnomAD3 genomes
AF:
0.446
AC:
67579
AN:
151354
Hom.:
15616
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.517
Gnomad AMI
AF:
0.393
Gnomad AMR
AF:
0.406
Gnomad ASJ
AF:
0.338
Gnomad EAS
AF:
0.760
Gnomad SAS
AF:
0.414
Gnomad FIN
AF:
0.376
Gnomad MID
AF:
0.303
Gnomad NFE
AF:
0.410
Gnomad OTH
AF:
0.425
GnomAD2 exomes
AF:
0.407
AC:
88438
AN:
217250
AF XY:
0.407
show subpopulations
Gnomad AFR exome
AF:
0.503
Gnomad AMR exome
AF:
0.297
Gnomad ASJ exome
AF:
0.331
Gnomad EAS exome
AF:
0.735
Gnomad FIN exome
AF:
0.379
Gnomad NFE exome
AF:
0.395
Gnomad OTH exome
AF:
0.382
GnomAD4 exome
AF:
0.417
AC:
587654
AN:
1408178
Hom.:
126745
Cov.:
30
AF XY:
0.416
AC XY:
291293
AN XY:
700296
show subpopulations
African (AFR)
AF:
0.496
AC:
15275
AN:
30766
American (AMR)
AF:
0.326
AC:
11667
AN:
35806
Ashkenazi Jewish (ASJ)
AF:
0.339
AC:
8528
AN:
25126
East Asian (EAS)
AF:
0.726
AC:
27623
AN:
38036
South Asian (SAS)
AF:
0.389
AC:
29992
AN:
77198
European-Finnish (FIN)
AF:
0.387
AC:
20554
AN:
53066
Middle Eastern (MID)
AF:
0.368
AC:
2088
AN:
5668
European-Non Finnish (NFE)
AF:
0.412
AC:
446850
AN:
1083968
Other (OTH)
AF:
0.428
AC:
25077
AN:
58544
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.431
Heterozygous variant carriers
0
15019
30037
45056
60074
75093
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
13832
27664
41496
55328
69160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.446
AC:
67631
AN:
151472
Hom.:
15627
Cov.:
0
AF XY:
0.444
AC XY:
32884
AN XY:
73988
show subpopulations
African (AFR)
AF:
0.517
AC:
21325
AN:
41254
American (AMR)
AF:
0.405
AC:
6177
AN:
15236
Ashkenazi Jewish (ASJ)
AF:
0.338
AC:
1168
AN:
3454
East Asian (EAS)
AF:
0.760
AC:
3869
AN:
5094
South Asian (SAS)
AF:
0.413
AC:
1988
AN:
4810
European-Finnish (FIN)
AF:
0.376
AC:
3947
AN:
10500
Middle Eastern (MID)
AF:
0.301
AC:
88
AN:
292
European-Non Finnish (NFE)
AF:
0.410
AC:
27817
AN:
67820
Other (OTH)
AF:
0.425
AC:
896
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
1834
3668
5501
7335
9169
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
618
1236
1854
2472
3090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.411
Hom.:
2196
Asia WGS
AF:
0.564
AC:
1962
AN:
3476

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

May 09, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Primary ciliary dyskinesia Benign:2
Aug 12, 2015
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Jul 17, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.77
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs57952953; hg19: chr7-21659554; COSMIC: COSV104410039; API